Shop
Showing 1025–1040 of 1229 results
-
Article: Revision of the guidelines ‘Care in the dying phase’
€3.03 Only for registered clients -
Article: Ribociclib plus endocrine therapy prolongs the survival of premenopausal women with advanced breast cancer
€3.03 Only for registered clients -
Article: Risk factors associated with bladder cancer occurrence and recurrence: an epidemiological and clinical approach
€3.03 Only for registered clients -
Article: Robot-assisted radical prostatectomy, an update of the current evidence
€3.03 Only for registered clients -
Article: Robust and sustained survival benefit for durvalumab after chemoradiotherapy in unresectable stage III non-small cell lung cancer
€3.03 Only for registered clients -
Article: Role and usefulness of an outpatient clinic for patients on oral anticancer therapy: 5-year experience in a general hospital in Belgium and review of the literature
€3.03 Only for registered clients -
Article: Role of glucocorticoid receptor-mediated effects on the colon cancer microenvironment
€3.03 Only for registered clients -
Article: Role of immune checkpoint inhibitors in small cell lung cancer treatment
€3.03 Only for registered clients -
Article: Role of the pharmacist in oncology: pharmaceutical care for patients treated with oral anticancer drugs
€3.03 Only for registered clients -
Article: Role of vaccination in oropharyngeal cancer prevention
€3.03 Only for registered clients -
Article: Sacituzumab Govitecan for patients with metastatic triple negative breast cancer
€3.03 Only for registered clients -
Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab
€3.03 Only for registered clients -
Article: Screening for dihydropyrimidine dehydrogenase deficiency to prevent severe fluoropyrimidine-associated toxicity
€3.03 Only for registered clients -
Article: Screening for occult cancer in patients with unprovoked venous thromboembolism: Belgian expert guidance
€3.03 Only for registered clients -
Article: Second Belgian multidisciplinary meeting on urological cancers held in Brussels – March 28, 2015
€3.03 Only for registered clients -
Article: Second-line treatment of non-small cell lung cancer adenocarcinoma patients not harbouring an oncogene driver mutation anno 2017–2018: A consensus group meeting
€3.03 Only for registered clients